173 related articles for article (PubMed ID: 33345684)
1. Ropivacaine inhibits the proliferation and migration of colorectal cancer cells through ITGB1.
Wang X; Li T
Bioengineered; 2021 Dec; 12(1):44-53. PubMed ID: 33345684
[TBL] [Abstract][Full Text] [Related]
2. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
Yang W; Xie T
Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
[TBL] [Abstract][Full Text] [Related]
3. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network.
Yang J; Hou Y; Zhou M; Wen S; Zhou J; Xu L; Tang X; Du YE; Hu P; Liu M
Int J Biochem Cell Biol; 2016 Feb; 71():62-71. PubMed ID: 26693891
[TBL] [Abstract][Full Text] [Related]
4. β1 integrin mediates colorectal cancer cell proliferation and migration through regulation of the Hedgehog pathway.
Song J; Zhang J; Wang J; Wang J; Guo X; Dong W
Tumour Biol; 2015 Mar; 36(3):2013-21. PubMed ID: 25387809
[TBL] [Abstract][Full Text] [Related]
5. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
Liu L; Yang X; Li NF; Lin L; Luo H
Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
[No Abstract] [Full Text] [Related]
6. Maspin suppresses cell invasion and migration in gastric cancer through inhibiting EMT and angiogenesis via ITGB1/FAK pathway.
Wang N; Chang LL
Hum Cell; 2020 Jul; 33(3):663-675. PubMed ID: 32409959
[TBL] [Abstract][Full Text] [Related]
7. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
[TBL] [Abstract][Full Text] [Related]
8. Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression.
Qin A; Liu Q; Wang J
Drug Dev Res; 2020 Sep; 81(6):700-707. PubMed ID: 32314406
[TBL] [Abstract][Full Text] [Related]
9. FRK suppresses human glioma growth by inhibiting ITGB1/FAK signaling.
Wang J; Cai C; Nie D; Song X; Sun G; Zhi T; Li B; Qi J; Zhang J; Chen H; Shi Q; Yu R
Biochem Biophys Res Commun; 2019 Oct; 517(4):588-595. PubMed ID: 31395336
[TBL] [Abstract][Full Text] [Related]
10. β1 integrin modulates tumor growth and apoptosis of human colorectal cancer.
Song J; Zhang J; Wang J; Cao Z; Wang J; Guo X; Dong W
Oncol Rep; 2014 Jul; 32(1):302-8. PubMed ID: 24807392
[TBL] [Abstract][Full Text] [Related]
11. Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis.
Zhu X; Wang K; Chen Y
Toxicol In Vitro; 2020 Dec; 69():104973. PubMed ID: 32818624
[TBL] [Abstract][Full Text] [Related]
12. Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.
Liu C; Qu L; Zhao C; Shou C
J Exp Clin Cancer Res; 2018 Jun; 37(1):117. PubMed ID: 29903032
[TBL] [Abstract][Full Text] [Related]
13. Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
Kurozumi A; Goto Y; Matsushita R; Fukumoto I; Kato M; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
Cancer Sci; 2016 Jan; 107(1):84-94. PubMed ID: 26509963
[TBL] [Abstract][Full Text] [Related]
14. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
[TBL] [Abstract][Full Text] [Related]
15. Evodiamine exerts anticancer effects via induction of apoptosis and autophagy and suppresses the migration and invasion of human colon cancer cells.
Wang D; Ge S; Chen Z; Song Y
J BUON; 2019; 24(5):1824-1829. PubMed ID: 31786843
[TBL] [Abstract][Full Text] [Related]
16. Biological Characteristics and Clinical Significance of ITGB1 and RHOC in Patients With Recurrent Colorectal Cancer.
Ha YJ; Tak KH; Kim SK; Kim CW; Lee JL; Roh SA; Cho DH; Kim SY; Kim YS; Kim JC
Anticancer Res; 2019 Sep; 39(9):4853-4864. PubMed ID: 31519588
[TBL] [Abstract][Full Text] [Related]
17. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
[TBL] [Abstract][Full Text] [Related]
18. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
[TBL] [Abstract][Full Text] [Related]
19. A disintegrin and metalloproteinase 22 activates integrin β1 through its disintegrin domain to promote the progression of pituitary adenoma.
Xing B; Lei Z; Wang Z; Wang Q; Jiang Q; Zhang Z; Liu X; Qi Y; Li S; Guo X; Liu Y; Li X; Shu K; Zhang H; Bartsch JW; Nimsky C; Huang Y; Lei T
Neuro Oncol; 2024 Jan; 26(1):137-152. PubMed ID: 37555799
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.
Zhang L; Zou W
Mol Med Rep; 2015 Dec; 12(6):7869-76. PubMed ID: 26497667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]